I have spent nearly my entire career at the intersection of life sciences product promotion, regulatory compliance, and enterprise content management. With Vodori’s co-founders, I cut my teeth implementing Documentum’s web content management platform. We later combined life sciences content technology with digital agency services, and eight years ago pivoted to build Vodori’s MLR platform. For nearly all of that time, the primary emphasis for value creation was on document approval efficiency.
To be fair, we put a lot of energy into content effectiveness, but that’s a difficult thing to do well across all channels, for all content, in a way that aligns to stakeholder agendas. It’s a priority then and now. But the unquestionable focus was work efficiency: how quickly (calendar time) and how easily (labor time) could we get compliant content to market?
The priority was collaborating on a document through a compliant and zippy workflow.
As I reflect on the last several years, there’s a clear convergence of signals that is materially disrupting the document + workflow center of gravity. Here’s what changed, and where I think it leads.
Together they point to the same conclusion: AI has to be integral rather than bolted on, and the asset worth building around is governed knowledge, not documents.
Our partnership with Salesforce, together with our work across a broad customer base, gives us a front-row seat as life sciences organizations replace closed, single-vendor technology stacks with interoperable, best-in-class platforms. This is what modern software architectures look like. Competition and interoperability drive innovation and real value for customers, and it’s a thrill to be part of the changes in life sciences.
Vendor lock-in is bad. Choice is good. And the best commercial teams are leaning in, redefining their digital commercial stack.
But even after a well-executed implementation and integration program, a nagging challenge remained. CRM. DAM. MLR. Salesforce Effectiveness. Master Data Management. Marketing Automation. The parts are all there. They’re good. They’re talking to each other. But the value is still largely the sum of the parts.
As AI makes software functionality faster and less expensive to (re)produce, the conversation has shifted toward where durable enterprise value accrues. The new moat? Proprietary data, the same data that AI eats to make an organization more effective. Bonus points to those of us with deep industry domain expertise, even better if there’s a compliance angle.
So while I don’t think investors own the strategy, I do think it’s worth studying how professional analysts bet on the future. And for our industry, that proprietary data isn’t hypothetical. It’s sitting inside every completed review.
The startup ecosystem is full of smart teams tackling the content compliance challenge. If nothing else, they’ve demonstrated broad agreement that AI belongs in regulated content workflows. But they also exposed an architectural limitation.
Many of these solutions operate outside the validated quality system. That separation makes experimentation easier, but it also means the intelligence is external to the core platform, isolated to external work and use cases. The disconnected capabilities orbit the governed platform like a satellite.
Three years ago, the answer from many of our customers about Vodori’s use of AI was simply, “No way.”
Eighteen months ago it became, “Keep us posted…but make sure we can turn it off.”
Today, the tipping point has clearly arrived, driven in no small part by the remarkable progress in large language models. Inside Vodori, AI now plays major roles in product development, customer onboarding, sales, marketing, and operations. By “major,” I mean the job descriptions of nearly every Vodorian is changing every few months as our own flow of work changes.
When I triangulate what we’ve learned from customers, from the startup landscape, and from our own experience with AI, the conclusion feels surprisingly straightforward.
AI must be integral, part of the core DNA, not a standalone module orbiting a quality system.
Perhaps more importantly, the real asset now is the governed knowledge behind every document: the approved claims, supporting evidence, scientific references, policies, prior decisions, brand standards, and institutional expertise. “Documents” are now just a container of knowledge at a point in time.
That distinction is the whole argument. A document is a snapshot. The knowledge that produced it is the durable asset: why this claim was approved, which reference supports it, what a reviewer decided last quarter and on what basis. In most organizations today that knowledge exists, but it’s trapped in completed files and individual memory. It can’t be queried, applied, or improved. So teams rebuild it, piece by piece, on the next project.
Once we arrived at that conclusion, the implications for our own platform became obvious. The new target: build an enterprise architecture that captures, governs, compounds, and operationalizes organizational knowledge.
That’s the journey that led us to introduce what we believe is the industry’s first Regulated Content Intelligence Platform (RCIP). RCIP combines two capabilities:
RCIP enables organizations to create, review, distribute, and continuously improve regulated content while keeping human expertise, compliance, and performance at the center.
For our life sciences customers, this means moving beyond viewing MLR as an integrated but separate island for compliance review workflows. Review becomes part of a broader recursive loop that captures organizational knowledge and compounds the value of this knowledge with each cycle.
Practically, that should look like:
That’s the difference between a workflow that processes documents and a system that gets smarter.
Frustrated with how much knowledge your team rebuilds on every project? Vodori brings governed knowledge and AI together inside the validated system, not alongside it.
We’re building RCIP for life sciences. But I know this architectural pattern extends wider.
The obligations of “truthful, non-misleading” product promotion are universal. AI is already lowering the cost of creating and reviewing communications, but it also lowers the cost of enforcement for regulatory bodies, competitors, and whistleblowers. Our evolving customer base outside of life sciences proves this point. This shift-left approach to content compliance applies to more than life sciences, and the urgency is growing.
The market is open for business. Swift, bold execution wins, and I don’t think there has ever been a better moment for companies to challenge long-standing assumptions. I’m incredibly proud of our team for having the conviction to reinvent a category that has remained largely unchanged for decades. And I’m grateful to our customers and partners who have shaped our thinking along the way.
If the last thirty years was the era of compliance workflows for documents, the next twenty will be built around governed knowledge.
We’re excited to help build that future.
What is a Regulated Content Intelligence Platform (RCIP)?
Vodori’s Regulated Content Intelligence Platform™ is an enterprise software category purpose-built for life sciences that unifies two capabilities: a system of record for governed knowledge, and a system of intelligence that applies AI to that knowledge across authoring, review, approval, and distribution. Unlike a document management system, it treats the knowledge behind content (claims, evidence, references, policies, prior decisions) as the primary asset.
What does “governed knowledge” mean in regulated content?
Governed knowledge is the approved, traceable information behind every piece of regulated content: approved claims, supporting evidence, scientific references, policies, prior review decisions, brand standards, and institutional expertise. It is “governed” because it lives inside the validated quality system with version control and audit trail, rather than in scattered files and individual memory.
How is RCIP different from an AI precheck tool?
Most AI precheck solutions operate outside the validated quality system. That makes them easier to experiment with, but it also means the intelligence is external to the core platform and the insights don’t accumulate. RCIP embeds AI inside the governed system, so each review cycle strengthens the knowledge foundation the next one draws on.
Does RCIP replace MLR review?
No. Human expertise, compliance, and accountability stay at the center. What changes is that MLR stops being a separate island for approval workflows and becomes part of a recursive loop, so reviewers spend less time re-establishing what was already decided and more time on scientific accuracy and regulatory judgment.
Is governed knowledge only relevant to pharma and medtech?
No. The obligation to make truthful, non-misleading product claims applies across regulated and consumer categories. As AI lowers the cost of enforcement for regulators, competitors, and whistleblowers, the same architectural pattern becomes relevant well beyond life sciences.
The press release covers what ships when, including Content Preflight and the capability roadmap through 2027. Read the Announcement.
Want to see where knowledge is getting lost in your own review cycles? Learn more.